SAFETY PROFILE OF JAK-INHIBITORS VERSUS TNF-INHIBITORS IN REAL-WORLD CLINICAL PRACTICE: DATA FROM A MULTICENTER REGISTER

Hernandez-Cruz, B.Sanchez-Piedra, C.Freire Gonzalez, M.Busquets, N.Garcia-Gonzalez, J.Moreno, M.Blanco, J. M.Manrique Arija, S.Perez-Pampin, E.Sanchez-Alonso, F.Castrejon, I.BIOBADASER2025-01-072025-01-072021-06-010003-4967https://hdl.handle.net/10668/24594enSAFETY PROFILE OF JAK-INHIBITORS VERSUS TNF-INHIBITORS IN REAL-WORLD CLINICAL PRACTICE: DATA FROM A MULTICENTER REGISTERconference outputopen access10.1136/annrheumdis-2021-eular.26451468-2060https://ard.bmj.com/content/annrheumdis/80/Suppl_1/68.1.full.pdf692629300121